Kisqali / Kryxana (Ribociclib) Tablets
Ribociclib is an oral CDK4/6 inhibitor used with hormone therapy for HR-positive, HER2-negative breast cancer. Kisqali is the Novartis brand; Kryxana is the Indian-market brand, and generics are available. Live prices are on the product pages.
Live price and checkout stay on the shop page so existing product listings are not duplicated.
Authentic Ribociclib
Named packs with batch traceability. We do not relabel generics as originators.
Storage
Room temperature
Tracked shipping
Worldwide courier to USA, UK, UAE, EU, Australia and more.
Pharmacist support
24/7 guidance from Critical Kare Pharma for patients and caregivers.
What is Kisqali / Kryxana (Ribociclib)?
Ribociclib is usually taken once daily for 21 days followed by 7 days off, alongside an aromatase inhibitor or fulvestrant.
ECG, liver tests and blood counts are monitored during treatment.
Strength and dose reductions are decided by the oncologist.
Class: CDK4/6 inhibitor. Novartis (originator); Indian generics available.
Typical uses (as prescribed)
- HR+/HER2- advanced or metastatic breast cancer, with hormone therapy (as indicated)
- Early breast cancer at high risk of recurrence where approved
Packs in our catalog
These links go to the existing product pages (unchanged URLs).
Kisqali / Kryxana by country
Country hubs already rank for local searches — we link them rather than creating duplicate shop pages.
Kisqali / Kryxana FAQs
Is Kryxana the same as Kisqali?
How many tablets are in a cycle?
Is generic ribociclib available?
Continue to the Kisqali / Kryxana product page
Availability and USD pricing live only on the shop SKU so current Google product listings stay intact.
Information and pharmacy-access support only — not medical advice, diagnosis, or a treatment plan. Always follow your oncologist. Prescription required for oncology medicines.